Compare FLGC & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLGC | GCTK |
|---|---|---|
| Founded | 2019 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 6.2M |
| IPO Year | 2021 | N/A |
| Metric | FLGC | GCTK |
|---|---|---|
| Price | $10.31 | $5.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.3K | ★ 19.7K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $57,609,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.13 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.71 | N/A |
| 52 Week Low | $6.80 | $4.22 |
| 52 Week High | $81.90 | $468.00 |
| Indicator | FLGC | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 51.86 | 51.05 |
| Support Level | $9.28 | $5.55 |
| Resistance Level | $11.22 | $6.71 |
| Average True Range (ATR) | 1.29 | 0.46 |
| MACD | 0.48 | 0.07 |
| Stochastic Oscillator | 45.75 | 56.02 |
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.